OXILAN (ioxilan) injection is a third-generation nonionic contrast medium offered by Guerbet in the U.S. It is a contrast agent used by radiologists, interventional radiologists and interventional cardiologists because of unique properties. It has low osmolality and viscosities among nonionic monomers in the U.S., which contributes to better patient outcomes such as patient comfort during intra-arterial injection and addresses physicians’ needs such as excellent image quality and easier injections.
OXILAN has a unique molecular structure which includes a hydrophobic region to promote molecular aggregation, thereby reducing the osmolality. Only those nonionic monomers that contain hydrophobic regions can achieve significantly lower solution osmolalities at diagnostically useful concentrations. This unique molecular design also features a terminal hydrophilic group, which results in reduced risk of side effects from binding with biological structures. The hydrophilic group also increases the solubility of the molecule.

Related Content

News | Contrast Media

August 3, 2022 — According to an open-access article in ARRS’ American Journal of Roentgenology (AJR), electronic health ...

Time August 03, 2022
arrow
News | Contrast Media

August 2, 2022 – A new update has been announced as the radiology world continues to address supply disruptions of ...

Time August 02, 2022
arrow
News | Contrast Media

July 18, 2022 — Fresenius Kabi announced today it will introduce a portfolio of generic contrast media agents in the ...

Time July 18, 2022
arrow
Sponsored Content | Case Study | SPECT-CT

A patient’s chance of recovery can be directly impacted when a diagnosis is missed or delayed. To get the right ...

Time July 06, 2022
arrow
Feature | Radiology Business | By Melinda Taschetta-Millane

Here is what you and your colleagues found to be most interesting in the field of medical imaging during the month of ...

Time July 05, 2022
arrow
News | Contrast Media

June 2, 2022 — Today, GE Healthcare issued a statement that it expects production capacity from its Shanghai facility to ...

Time June 02, 2022
arrow
Feature | Radiology Business | By Melinda Taschetta-Millane

Here is what you and your colleagues found to be most interesting in the field of medical imaging during the month of ...

Time June 01, 2022
arrow
News | Contrast Media

June 1, 2022 — The current shortage of iodinated contrast in the United States due to the COVID-19 related production ...

Time June 01, 2022
arrow
News | Artificial Intelligence

May 31, 2022 — Imaging Biometrics, LLC (IB), a subsidiary of IQ-AI Limited, announced it has submitted an FDA 510(k) ...

Time May 31, 2022
arrow
News | Contrast Media

May 19 2022 — Recent disruptions in a pharmaceutical supply chain have impacted the global availability of GE Healthcare ...

Time May 19, 2022
arrow
Subscribe Now